PMI Impact Malaria
PMI Impact Malaria in Côte d'Ivoire
PMI Impact Malaria (IM) is the flagship global service delivery project of the U.S. President’s Malaria Initiative (PMI). To advance PMI’s goal of fighting malaria and saving lives, IM is supporting Côte d’Ivoire’s national malaria control program (NMCP) in its efforts to strengthen malaria service delivery.
IM began supporting Côte d’Ivoire’s NMCP in 2018 to improve malaria case management at the community and public facility levels, with an emphasis on protecting those who are most at risk—particularly young children and pregnant women.
To advance malaria service delivery in Côte d’Ivoire, IM is mainly focused on strengthening health worker competence, expanding community access to malaria prevention and treatment, and scaling up drug-based prevention for pregnant women.
Malaria Country Context
In Côte d’Ivoire, malaria is endemic throughout the whole year with the entire population of more than 24 million people at risk of malaria. Transmission peaks during the rainy season. The rains occur between May and July for the main season and between October and November for the secondary season, and with a tropical climate from March through May. The malaria parasite species Plasmodium falciparum causes the majority of infections.
Malaria continues to be a major public health problem in Côte d’Ivoire, with an estimated 3.4 million cases and 9,600 deaths in 2018. Testing rates are high, with the country’s health facilities reporting about 3.3 million confirmed malaria cases and an additional 200,000 confirmed cases at the community level.
This is PMI Impact Malaria’s geographic coverage in Côte d’Ivoire:
PMI Impact Malaria has supported Côte d’Ivoire’s NMCP in achieving these key accomplishments:
Tested 16,367 children for malaria at the community level and treated 13,128 of them in 27 health districts in Southeastern Côte d’Ivoire. Well-trained community health workers (CHWs) referred a further 8,400 children to health centers with suspected malaria.
Prevented malaria in pregnancy (MIP) for hundreds of thousands of women in Côte d’Ivoire through administering intermittent preventive treatment in pregnancy (IPTp) during antenatal care (ANC) visits in 45 health districts in Eastern Côte d’Ivoire. Since the beginning of the project, 334,005 pregnant women received their first dose of IPTp; 281,678 their second; 200,365 their third; and 64,633 their fourth. In addition, 283,026 pregnant women received an insecticide-treated bed net while at a health facility for an ANC visit.
Trained 2,219 health workers from the public and private sectors in case management of uncomplicated and severe malaria, MIP, and the use of rapid diagnostic tests (RDTs) to diagnose malaria in 45 districts in Eastern Côte d’Ivoire, including the capital Abidjan. A further 54 laboratory technicians, including 14 supervisors, received training in malaria microscopy.
Photo Credit: Mwangi Kirubi/PMI Impact Malaria, Côte d’Ivoire
Sources: PMI’s Côte d'Ivoire Country Brief, PMI’s Côte d'Ivoire Malaria Operational Plan FY 2020, 2019 World Malaria Report Côte d’Ivoire Country Profile, PMI Impact Malaria Côte d’Ivoire, and Côte d’Ivoire’s NMCP
The information provided on this website is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.